HOME >> MEDICINE >> NEWS
Men more at risk of recurrent blood clots than women

Men have a 50% higher relative risk of suffering from recurrent blood clots after a first episode than women, according to an article in this week's issue of The Lancet. The baseline frequency of recurrent blood clots is 25% after five years.

Dr Simon McRae from the Department of Haematology (Queen Elizabeth Hospital, Woodville, South Australia, Australia) and his colleagues from the Department of Medicine, McMaster University (Hamilton, Ontario, Canada) did a meta-analysis of studies involving both men and women who were being treated for either deep vein thrombosis or pulmonary embolism (in which a clot detaches from a deep vein and lodges in the lung). They looked at rates of recurrence of blood clots in patients after they had stopped taking preventative anticoagulant (blood-thinning) medication.

A total of 5416 patients were enrolled in 15 eligible studies, 50% were men and 50% women. There were 816 recurrent blood clots, of which 523 (64%) were in men and 293 (36%) were in women.

The cause of heightened risk in men is unclear, but the authors state it could be attributable to differences in age, body mass index, or inherited susceptibility to blood clots. Dr Simon McRae writes: "further prospective studies are needed before a firm recommendation can be made to incorporate patient sex into decision making on duration of anticoagulant treatment in individual patients."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
27-Jul-2006


Page: 1

Related medicine news :

1. Vorinostat shows anti-cancer activity in recurrent gliomas
2. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
3. Popular statin reduces recurrent stroke risk
4. Measurement of urinary protein can help detect recurrent bladder cancer
5. Point-of-care test proves more effective for recurrent bladder cancer than conventional lab test
6. Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis
7. Study suggests mechanism for recurrent sudden infant death syndrome
8. Biomarkers may provide important information for patients at risk for recurrent ischemic stroke
9. Treatment regimen offers greater survival advantage for recurrent head and neck cancers
10. Biomarkers used to predict recurrent disease in hepatitis C transplant patients
11. Antidepressants may lower risk of recurrent heart attack in depressed heart attack patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men more risk recurrent blood clots than women

(Date:7/29/2015)... ... , ... This year, the threat of flooding is higher in many areas ... water, mold is not far behind. Paul Davis, a leading provider of property restoration ... damage. Paul Davis is regularly called on to handle these types of emergencies, although ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering a nationally ... Kalamazoo Strength & Conditioning. , The name change coincides with the release of ... training center over the past three years,” according to Jack Kelly, the center’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of ... Rotator Cuff System, a new implant to treat a common source of shoulder pain ... regeneration of additional tendon tissue, which could allow for faster healing and a decreased ...
(Date:7/29/2015)... ... July 29, 2015 , ... Wedding season is in full swing, which means bridal beauty ... of looking good on the big day. Every bride wants to look and feel beautiful, ... , According to a recent study by the American Academy of ...
(Date:7/29/2015)... ... July 29, 2015 , ... Fastline Publications, ... of 2015 on RFD-TV. , Fastline is dedicated to quality agricultural advertising, both ... contains the largest and freshest searchable agriculture equipment database in the world. The ...
Breaking Medicine News(10 mins):Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2
(Date:7/29/2015)... Calif. , July 29, 2015 /PRNewswire/ ... or the "Company"), the leading provider of ... sciences industry, serving markets including immunotherapies, stem ... manufacturers, animal health, and reproductive medicine, announced ... sale of common stock and warrants (the "Units") under ...
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/sxwk89/3d_metrology ) ... Market by Product (CMM, ODS, and VMM), Application (Automotive, ... (North America, Europe, APAC, RoW) - Global Forecast to ... The 3D metrology market was valued at $1,456.7 ... a rate of 7.11% during the forecast period. ...
(Date:7/29/2015)... DIEGO , July 29, 2015  ViaCyte, Inc., a privately-held ... for the treatment of diabetes in clinical trials, today announced the ... STEP ONE, or S afety, T olerability, and ... One Diabetes.  The new site, which is the first in ... Alberta Hospitals in Edmonton , Alberta.  ...
Breaking Medicine Technology:Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Global 3D Metrology Market 2015-2020: Products (CMM, ODS, and VMM) & Applications (Automotive, Aerospace, Energy & Power, Medical and Electronics) 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4
Cached News: